GENE ONLINE|News &
Opinion
Blog

Series A Funding
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
Protect Bio Completed Series A Fundraising, Establishing New Platform for Animal Therapy
2023-12-11Partner
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Flossy Raises 14.7M to Expand Oral Care Accessibility
2022-08-19
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Boston’s Kelonia Therapeutics Bags $50M to Accelerate Genetic Medicines
2022-04-29
Pheast Gets a $76 Million Series A to Feed Pipeline of Immune Checkpoint Inhibitors
2022-04-27
tRNA Startup Clinches $24 Million from ARCH, Takeda and 8VC to Fix Protein Mutations
2022-02-25
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
SK Biopharm Spinout Launches with $180 Million to Bring Neuroscience Drugs to China
2021-11-12
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Replicate Bioscience Secures $40 Million in Series A to Advance RNA Therapeutics
2021-09-10
1 2 3
LATEST
Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I
2024-07-23
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
EVENT
Scroll to Top